MX9602772A - Microgranules of 5-nitro imidazole derivatives. - Google Patents
Microgranules of 5-nitro imidazole derivatives.Info
- Publication number
- MX9602772A MX9602772A MX9602772A MX9602772A MX9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A MX 9602772 A MX9602772 A MX 9602772A
- Authority
- MX
- Mexico
- Prior art keywords
- microgranules
- imidazole derivatives
- nitro imidazole
- nitro
- galenic form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A galenic form of 5-nitro imidazole derivatives, including a combination of microgranules of 5-nitro imidazole derivatives, i.e. enteric microgranules and sustained release microgranules, pharmaceutical compositions containing same, and microgranules for use as intermediates in the preparation of said galenic form, are disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9400394A FR2715067B1 (en) | 1994-01-14 | 1994-01-14 | New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract. |
PCT/FR1995/000039 WO1995019168A1 (en) | 1994-01-14 | 1995-01-12 | Microgranules of 5-nitro imidazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9602772A true MX9602772A (en) | 1997-05-31 |
Family
ID=9459066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9602772A MX9602772A (en) | 1994-01-14 | 1995-01-12 | Microgranules of 5-nitro imidazole derivatives. |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPH09507499A (en) |
KR (1) | KR100320140B1 (en) |
CN (1) | CN1088357C (en) |
AT (1) | ATE187068T1 (en) |
AU (1) | AU705570B2 (en) |
BR (1) | BR9506507A (en) |
CZ (1) | CZ286080B6 (en) |
DE (1) | DE69513632T2 (en) |
DK (1) | DK0739201T3 (en) |
ES (1) | ES2139883T3 (en) |
MA (1) | MA23429A1 (en) |
MX (1) | MX9602772A (en) |
NZ (1) | NZ279238A (en) |
OA (1) | OA10583A (en) |
PL (1) | PL178424B1 (en) |
PT (1) | PT739201E (en) |
RU (1) | RU2152212C1 (en) |
SK (1) | SK282066B6 (en) |
UA (1) | UA28031C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4331930B2 (en) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | High content granules of acid labile drugs |
KR20170052626A (en) | 2014-09-05 | 2017-05-12 | 심바이오믹스 세러퓨틱스 엘엘씨 | Secnidazole for use in the treatment of bacterial vaginosis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
DE3822095A1 (en) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF |
CA2082398C (en) * | 1990-05-14 | 2004-06-29 | Gary R. Jernberg | Surgical implant and method incorporating chemotherapeutic agents |
-
1995
- 1995-01-12 MX MX9602772A patent/MX9602772A/en not_active IP Right Cessation
- 1995-01-12 PT PT95907683T patent/PT739201E/en unknown
- 1995-01-12 RU RU96117257/14A patent/RU2152212C1/en not_active IP Right Cessation
- 1995-01-12 AU AU15803/95A patent/AU705570B2/en not_active Ceased
- 1995-01-12 DE DE69513632T patent/DE69513632T2/en not_active Expired - Fee Related
- 1995-01-12 CZ CZ19962055A patent/CZ286080B6/en not_active IP Right Cessation
- 1995-01-12 ES ES95907683T patent/ES2139883T3/en not_active Expired - Lifetime
- 1995-01-12 UA UA96083232A patent/UA28031C2/en unknown
- 1995-01-12 DK DK95907683T patent/DK0739201T3/en active
- 1995-01-12 NZ NZ279238A patent/NZ279238A/en unknown
- 1995-01-12 BR BR9506507A patent/BR9506507A/en not_active IP Right Cessation
- 1995-01-12 CN CN95191222A patent/CN1088357C/en not_active Expired - Fee Related
- 1995-01-12 KR KR1019960703797A patent/KR100320140B1/en not_active IP Right Cessation
- 1995-01-12 AT AT95907683T patent/ATE187068T1/en not_active IP Right Cessation
- 1995-01-12 PL PL95315530A patent/PL178424B1/en not_active IP Right Cessation
- 1995-01-12 JP JP7518878A patent/JPH09507499A/en active Pending
- 1995-01-12 SK SK914-96A patent/SK282066B6/en unknown
- 1995-01-13 MA MA23756A patent/MA23429A1/en unknown
-
1996
- 1996-07-12 OA OA60863A patent/OA10583A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK91496A3 (en) | 1996-12-04 |
OA10583A (en) | 2002-07-10 |
PL178424B1 (en) | 2000-04-28 |
DK0739201T3 (en) | 2000-05-01 |
AU705570B2 (en) | 1999-05-27 |
SK282066B6 (en) | 2001-10-08 |
MA23429A1 (en) | 1995-10-01 |
PT739201E (en) | 2000-05-31 |
NZ279238A (en) | 1998-03-25 |
CN1138826A (en) | 1996-12-25 |
KR100320140B1 (en) | 2002-07-02 |
BR9506507A (en) | 1997-09-09 |
CN1088357C (en) | 2002-07-31 |
CZ286080B6 (en) | 2000-01-12 |
ATE187068T1 (en) | 1999-12-15 |
PL315530A1 (en) | 1996-11-12 |
RU2152212C1 (en) | 2000-07-10 |
UA28031C2 (en) | 2000-10-16 |
CZ205596A3 (en) | 1996-10-16 |
ES2139883T3 (en) | 2000-02-16 |
JPH09507499A (en) | 1997-07-29 |
AU1580395A (en) | 1995-08-01 |
DE69513632D1 (en) | 2000-01-05 |
DE69513632T2 (en) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
MXPA01008611A (en) | Compounds and compositions for delivering active agents. | |
HUP9601566A2 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
EP1093819A3 (en) | Compounds and compositions for delivering active agents | |
IL110481A0 (en) | 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0001943A3 (en) | Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
AP1253A (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate. | |
HUP0203403A3 (en) | New imidazole derivatives, pharmaceutical compositions containing them and their use | |
IL140710A0 (en) | Pulmonary delivery of active agents | |
HUP0004225A3 (en) | Pyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
HUP0202263A3 (en) | Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them | |
SI0918059T1 (en) | Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them | |
HUP0002324A3 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
HUP0002952A3 (en) | Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them | |
AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
AU6551198A (en) | Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them | |
IL127518A (en) | Substituted heterocyclic benzocycloalkenes, their preparation and pharmaceutical compositions having an analgesic effect | |
AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
HUP0103184A3 (en) | Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them | |
MX9602772A (en) | Microgranules of 5-nitro imidazole derivatives. | |
IL104347A0 (en) | Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
NZ272089A (en) | Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions | |
HUP0001010A3 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them | |
IL107175A0 (en) | Benzimidazoles, their preparation and pharmaceutical compositions comprising them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |